$PETS
PETMED EXPRESS INC Stock $pets

$pets Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-K Financial Statement

#000143774920011720 Filed on May 26, 2020

Income Statement

Concept	2020 Q1	2019 Q4	2019 Q3
Revenue	$74.29M	$59.92M	$69.94M
YoY Change	15.06%	-0.25%	-2.04%
Cost Of Revenue	$52.60M	$42.22M	$49.93M
YoY Change	19.98%	3.76%	8.22%
Gross Profit	$21.69M	$17.70M	$20.00M
YoY Change	4.64%	-8.69%	-20.8%
Gross Profit Margin	29.19%	29.54%	28.6%
Selling, General & Admin	$12.62M	$9.200M	$11.06M
YoY Change	2.1%	-2.23%	-3.83%
% of Gross Profit	58.19%	51.99%	55.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$560.0K	$562.0K	$572.0K
YoY Change	-1.75%	1.08%	3.62%
% of Gross Profit	2.58%	3.18%	2.86%
Operating Expenses	$13.17M	$9.765M	$11.63M
YoY Change	1.93%	-2.04%	-3.49%
Operating Profit	$8.513M	$7.932M	$8.371M
YoY Change	9.11%	-15.73%	-36.6%
Interest Expense	$300.0K	$420.0K	$460.0K
YoY Change	-45.45%	-17.65%	6.98%
% of Operating Profit	3.52%	5.3%	5.5%
Other Income/Expense, Net	$310.0K	$722.0K	$763.0K
YoY Change	19.23%	-5.37%	11.71%
Pretax Income	$9.120M	$8.654M	$9.134M
YoY Change	5.92%	-14.96%	-34.22%
Income Tax	$2.120M	$1.800M	$2.469M
% Of Pretax Income	23.25%	20.8%	27.03%
Net Earnings	$7.003M	$6.840M	$6.665M
YoY Change	5.79%	-12.16%	-38.01%
Net Earnings / Revenue	9.43%	11.42%	9.53%
Basic Earnings Per Share		$0.34	$0.33
Diluted Earnings Per Share	$0.35	$0.34	$0.33
COMMON SHARES
Basic Shares Outstanding	20.17M	19.98M	19.96M
Diluted Shares Outstanding		19.99M	19.97M

Balance Sheet

Concept	2020 Q1	2019 Q4	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$103.8M	$92.40M	$94.90M
YoY Change	3.28%	-0.86%	8.96%
Cash & Equivalents	$103.8M	$92.37M	$94.90M
Short-Term Investments
Other Short-Term Assets	$3.500M	$4.200M	$2.800M
YoY Change	150.0%	223.08%	180.0%
Inventory	$17.90M	$24.20M	$19.10M
Prepaid Expenses
Receivables	$3.843M	$2.052M	$1.466M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$129.0M	$122.8M	$118.3M
YoY Change	2.05%	-4.44%	-0.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$25.45M	$25.92M	$26.41M
YoY Change	-6.23%	-6.04%	-5.95%
Goodwill
YoY Change
Intangibles	$860.0K	$860.0K	$860.0K
YoY Change	0.0%	0.0%	0.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$26.31M	$26.78M	$27.27M
YoY Change	-6.04%	-5.86%	-5.77%
TOTAL ASSETS
Total Short-Term Assets	$129.0M	$122.8M	$118.3M
Total Long-Term Assets	$26.31M	$26.78M	$27.27M
Total Assets	$155.3M	$149.5M	$145.5M
YoY Change	0.58%	-4.7%	-1.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$19.66M	$16.64M	$15.16M
YoY Change	20.79%	-17.99%	6.14%
Accrued Expenses	$4.200M	$3.200M	$2.900M
YoY Change	75.0%	14.29%	3.57%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$24.34M	$20.73M	$18.55M
YoY Change	30.69%	-10.09%	8.84%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$24.34M	$20.73M	$18.55M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$25.31M	$21.83M	$19.95M
YoY Change	28.19%	-9.25%	9.41%
SHAREHOLDERS EQUITY
Retained Earnings	$126.2M	$124.6M	$123.2M
YoY Change	3.28%	2.88%	3.6%
Common Stock	$20.00K	$20.00K	$20.00K
YoY Change	-4.76%	-4.76%	-4.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$130.0M	$127.7M	$125.6M
YoY Change
Total Liabilities & Shareholders Equity	$155.3M	$149.5M	$145.5M
YoY Change	0.58%	-4.7%	-1.71%

Cashflow Statement

Concept	2020 Q1	2019 Q4	2019 Q3
OPERATING ACTIVITIES
Net Income	$7.003M	$6.840M	$6.665M
YoY Change	5.79%	-12.16%	-38.01%
Depreciation, Depletion And Amortization	$560.0K	$562.0K	$572.0K
YoY Change	-1.75%	1.08%	3.62%
Cash From Operating Activities	$17.26M	$4.290M	$17.25M
YoY Change	31.66%	-63.11%	-1158.28%
INVESTING ACTIVITIES
Capital Expenditures	-$480.0K	-$1.410M	-$230.0K
YoY Change	336.36%	2250.0%	64.29%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$480.0K	-$1.410M	-$230.0K
YoY Change	336.36%	2250.0%	64.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-5.390M	-5.400M	-5.530M
YoY Change	-4.43%	-2.35%	-2.3%
NET CHANGE
Cash From Operating Activities	17.26M	4.290M	17.25M
Cash From Investing Activities	-480.0K	-1.410M	-230.0K
Cash From Financing Activities	-5.390M	-5.400M	-5.530M
Net Change In Cash	11.39M	-2.520M	11.49M
YoY Change	54.76%	-141.72%	-254.64%
FREE CASH FLOW
Cash From Operating Activities	$17.26M	$4.290M	$17.25M
Capital Expenditures	-$480.0K	-$1.410M	-$230.0K
Free Cash Flow	$17.74M	$5.700M	$17.48M
YoY Change	34.19%	-51.24%	-1273.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001040130
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20166382
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019Q3	dei	Entity Public Float EntityPublicFloat	349100000
CY2020	dei	Entity Registrant Name EntityRegistrantName	PETMED EXPRESS INC
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3233000
CY2019	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	22593000
CY2018	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	19206000
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Security12b Title Security12bTitle	Common Stock, par value $.001 per share
CY2020	dei	Trading Symbol TradingSymbol	pets
CY2020Q1	pets	Accrued Credit Card Fees Current AccruedCreditCardFeesCurrent	494000
CY2019Q1	pets	Accrued Credit Card Fees Current AccruedCreditCardFeesCurrent	404000
CY2020Q1	pets	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	4214000
CY2019Q1	pets	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	2351000
CY2020Q1	pets	Accrued Merchandise Credits And Rewards Current AccruedMerchandiseCreditsAndRewardsCurrent	674000
CY2019Q1	pets	Accrued Merchandise Credits And Rewards Current AccruedMerchandiseCreditsAndRewardsCurrent	70000
CY2020Q1	pets	Accrued Sales Returns And Allowances Current AccruedSalesReturnsAndAllowancesCurrent	244000
CY2019Q1	pets	Accrued Sales Returns And Allowances Current AccruedSalesReturnsAndAllowancesCurrent	184000
CY2020	pets	Defined Contribution Plan With Individual Age DefinedContributionPlanWithIndividualAge	P21Y
CY2018	pets	Income Tax Expense Reduction Increase Due To Blended Rate IncomeTaxExpenseReductionIncreaseDueToBlendedRate	1900000
CY2012Q3	pets	Percentage Of Automatic Increase In Shares Available For Issuance PercentageOfAutomaticIncreaseInSharesAvailableForIssuance	0.1
CY2020	pets	Revenue From Contract With Customer Percentage RevenueFromContractWithCustomerPercentage	1
CY2019	pets	Revenue From Contract With Customer Percentage RevenueFromContractWithCustomerPercentage	1
CY2018	pets	Revenue From Contract With Customer Percentage RevenueFromContractWithCustomerPercentage	1
CY2020	pets	Revenue From Contract With Customer Variance RevenueFromContractWithCustomerVariance	706000
CY2019	pets	Revenue From Contract With Customer Variance RevenueFromContractWithCustomerVariance	9619000
CY2020	pets	Revenue From Contract With Customer Variance Percentage RevenueFromContractWithCustomerVariancePercentage	0.002
CY2019	pets	Revenue From Contract With Customer Variance Percentage RevenueFromContractWithCustomerVariancePercentage	0.035
CY2020	pets	Transfer Of Property And Equipment To Current Assets TransferOfPropertyAndEquipmentToCurrentAssets	1745000
CY2019	pets	Transfer Of Property And Equipment To Current Assets TransferOfPropertyAndEquipmentToCurrentAssets
CY2018	pets	Transfer Of Property And Equipment To Current Assets TransferOfPropertyAndEquipmentToCurrentAssets
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	19658000
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	16275000
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3843000
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2542000
CY2020Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	112000
CY2019Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	87000
CY2020Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	1242000
CY2019Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	685000
CY2020Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	471000
CY2019Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent
CY2020Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	267000
CY2019Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	281000
CY2020Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10654000
CY2019Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8397000
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3804000
CY2019Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	12478000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2575000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3097000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2822000
CY2020	us-gaap	Advertising Expense AdvertisingExpense	22748000
CY2019	us-gaap	Advertising Expense AdvertisingExpense	22148000
CY2018	us-gaap	Advertising Expense AdvertisingExpense	19255000
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	59000
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	39000
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	72120
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	126751
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	77350
CY2020Q1	us-gaap	Assets Assets	155323000
CY2019Q1	us-gaap	Assets Assets	154427000
CY2020Q1	us-gaap	Assets Current AssetsCurrent	129018000
CY2019Q1	us-gaap	Assets Current AssetsCurrent	126431000
CY2020Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	26305000
CY2019Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	27996000
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	100529000
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	77936000
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58730000
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	103762000
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.08
CY2019	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.06
CY2018	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.85
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20166000
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20674000
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20166000
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20674000
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	20000
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	21000
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 36pt; text-align: justify; text-indent: 0pt;"><div style="display: inline; font-weight: bold;">Business Concentrations</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 36pt;text-align:justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 36pt; text-align: justify; text-indent: 0pt;">The Company purchases its products from a variety of sources, including certain manufacturers, domestic distributors, and wholesalers. We have multiple suppliers for each of our products to obtain the lowest cost. There were <div style="display: inline; font-style: italic; font: inherit;">three</div> suppliers from whom we purchased approximately <div style="display: inline; font-style: italic; font: inherit;">60%</div> of all products in fiscal <div style="display: inline; font-style: italic; font: inherit;">2020.</div> There were <div style="display: inline; font-style: italic; font: inherit;">four</div> suppliers from whom we purchased approximately <div style="display: inline; font-style: italic; font: inherit;">50%</div> of all products in fiscal <div style="display: inline; font-style: italic; font: inherit;">2019.</div></div></div></div></div></div></div>
CY1998Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	4.05
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	202879000
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	188105000
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	175993000
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	7352000
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	9718000
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	15012000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	8193000
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	11256000
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	16598000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	841000
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1538000
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1586000
CY2020	us-gaap	Deferred Compensation Arrangement With Individual Requisite Service Period1 DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1	P1Y
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-135000
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	108000
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-83000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-151000
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	125000
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-92000
CY2020Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	970000
CY2019Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1121000
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-151000
CY2019	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	125000
CY2018	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-92000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-16000
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	17000
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-9000
CY2020Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	780000
CY2019Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	732000
CY2020Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	469000
CY2019Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	412000
CY2020Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	24000
CY2019Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	22000
CY2020Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	287000
CY2019Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	298000
CY2020Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	970000
CY2019Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1121000
CY2020Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1750000
CY2019Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1853000
CY2020	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	211000
CY2019	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	192000
CY2018	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	166000
CY2020	us-gaap	Depreciation Depreciation	2257000
CY2019	us-gaap	Depreciation Depreciation	2225000
CY2018	us-gaap	Depreciation Depreciation	2126000
CY2018	us-gaap	Dividends Common Stock DividendsCommonStock	17493000
CY2019	us-gaap	Dividends Common Stock DividendsCommonStock	21888000
CY2020	us-gaap	Dividends Common Stock DividendsCommonStock	21846000
CY2017Q2	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.20
CY2018Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.25
CY2018Q3	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.27
CY2020Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.27
CY2020Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	246000
CY2019Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	203000
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.29
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.84
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.83
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.62
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.84
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.82
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.315
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	322000
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-176000
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-1086000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25264000
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24767000
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24290000
CY2019Q2	us-gaap	Gross Profit GrossProfit	21861000
CY2019Q3	us-gaap	Gross Profit GrossProfit	20002000
CY2019Q4	us-gaap	Gross Profit GrossProfit	17697000
CY2020Q1	us-gaap	Gross Profit GrossProfit	21686000
CY2018Q2	us-gaap	Gross Profit GrossProfit	29954000
CY2018Q3	us-gaap	Gross Profit GrossProfit	25255000
CY2018Q4	us-gaap	Gross Profit GrossProfit	19381000
CY2019Q1	us-gaap	Gross Profit GrossProfit	20724000
CY2020	us-gaap	Gross Profit GrossProfit	81246000
CY2019	us-gaap	Gross Profit GrossProfit	95314000
CY2018	us-gaap	Gross Profit GrossProfit	97807000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	33893000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	49121000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	53789000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8042000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11381000
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16506000
CY2018	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	-430000
CY2020	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate
CY2019	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate
CY2018	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-430000
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	7118000
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	10315000
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	16943000
CY2020	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-47000
CY2019	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	9000
CY2018	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	1000
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	649000
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1233000
CY2018	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1078000
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	7140000
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	11051000
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	18046000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3383000
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1001000
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	53000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1492000
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	335000
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	596000
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	471000
CY2019	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable
CY2018	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-659000
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1820000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	5343000
CY2019	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-447000
CY2018	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	337000
CY2020	us-gaap	Increase Decrease In Finished Goods And Work In Process Inventories IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories	-3486000
CY2019	us-gaap	Increase Decrease In Finished Goods And Work In Process Inventories IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories	-1967000
CY2018	us-gaap	Increase Decrease In Finished Goods And Work In Process Inventories IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories	3109000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	376000
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	526000
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-137000
CY2020	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-582000
CY2019	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-206000
CY2018	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	788000
CY2020	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	10000
CY2019	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	10000
CY2018	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	10000
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4000
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	20000
CY2018	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	77000
CY2020Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	860000
CY2019Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	860000
CY2020Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	17884000
CY2019Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	21370000
CY2020Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	45000
CY2019Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	54000
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	1747000
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	1864000
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	658000
CY2020Q1	us-gaap	Liabilities Liabilities	25313000
CY2019Q1	us-gaap	Liabilities Liabilities	19747000
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	155323000
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	154427000
CY2020	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	246000
CY2019	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	203000
CY2018	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	240000
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	24343000
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	18626000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-33300000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-21925000
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17470000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2311000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-620000
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-703000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	38844000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	45138000
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	37379000
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	6665000
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	6840000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	7003000
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	12582000
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	10752000
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	7787000
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	6620000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	25851000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	37740000
CY2018	us-gaap	Net Income Loss NetIncomeLoss	37283000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2916000
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2947000
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1653000
CY2020	us-gaap	Operating Expenses OperatingExpenses	50269000
CY2019	us-gaap	Operating Expenses OperatingExpenses	49140000
CY2018	us-gaap	Operating Expenses OperatingExpenses	45671000
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	6161000
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	8371000
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	7932000
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	8513000
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	15757000
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	13203000
CY2018Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	9413000
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	7802000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	30977000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	46174000
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	52136000
CY2020Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	308000
CY2019Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	114000
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0
CY2018	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1169000
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1083000
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	995000
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11497000
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	21803000
CY2019	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	21925000
CY2018	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	17470000
CY1998Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	112187
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2311000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	620000
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	703000
CY2020Q1	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	4
CY2019Q1	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	4
CY1998Q2	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	4
CY2020Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY1998Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2020Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3000
CY2019Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3000
CY1998Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	250000
CY2020Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3000
CY2019Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3000
CY2020Q1	us-gaap	Preferred Stock Value PreferredStockValue	9000
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue	9000
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3529000
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1408000
CY2020Q1	us-gaap	Prepaid Taxes PrepaidTaxes
CY2019Q1	us-gaap	Prepaid Taxes PrepaidTaxes	582000
CY2020Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	36099000
CY2019Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	35533000
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	25445000
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27136000
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	191000
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	85000
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	112000
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	126177000
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	122172000
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	284125000
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	283419000
CY2018	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	273800000
CY2019Q2	us-gaap	Revenues Revenues	79988000
CY2019Q3	us-gaap	Revenues Revenues	69936000
CY2019Q4	us-gaap	Revenues Revenues	59915000
CY2020Q1	us-gaap	Revenues Revenues	74286000
CY2018Q2	us-gaap	Revenues Revenues	87390000
CY2018Q3	us-gaap	Revenues Revenues	71396000
CY2018Q4	us-gaap	Revenues Revenues	60068000
CY2019Q1	us-gaap	Revenues Revenues	64565000
CY2020Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	627000
CY2019Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	323000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	2822000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	3097000
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	2575000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	9000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	115000
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	150000
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	183000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	73000
CY1998Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	4
CY2018	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2019	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2006Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	20000000
CY2008Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	20000000
CY2019Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	30000000
CY2010Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	20000000
CY2020Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	28700000
CY2020	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	613000
CY2019	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	0
CY2020	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	11497000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	130010000
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	134680000
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	93366000
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	115731000
CY2020	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	-93000
CY2019	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	8000
CY2018	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	-150000
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 36pt; text-align: justify; text-indent: 0pt;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 36pt;text-align:justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 36pt; text-align: justify; text-indent: 0pt;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div></div>
CY2019Q1	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	39000
CY2018Q1	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	35000
CY2017Q1	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	27000
CY2020Q1	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	59000
CY2020	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	171000
CY2019	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	81000
CY2018	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	104000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20055000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20491000
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20433000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20041000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20461000
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20346000

Files In Submission

Name	View Source	Status
0001437749-20-011720-index-headers.html	Edgar Link	pending
0001437749-20-011720-index.html	Edgar Link	pending
0001437749-20-011720.txt	Edgar Link	pending
0001437749-20-011720-xbrl.zip	Edgar Link	pending
ex_187432.htm	Edgar Link	pending
ex_187433.htm	Edgar Link	pending
ex_187434.htm	Edgar Link	pending
ex_187435.htm	Edgar Link	pending
ex_187436.htm	Edgar Link	pending
ex_187437.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pets-20200331.xml	Edgar Link	completed
pets-20200331.xsd	Edgar Link	pending
pets-20200331_cal.xml	Edgar Link	unprocessable
pets-20200331_def.xml	Edgar Link	unprocessable
pets-20200331_lab.xml	Edgar Link	unprocessable
pets-20200331_pre.xml	Edgar Link	unprocessable
pets20200331_10k.htm	Edgar Link	pending
pets20200331_10kimg003.gif	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PETS
PETMED EXPRESS INC Stock $pets

2020 Q1 Form 10-K Financial Statement

#000143774920011720 Filed on May 26, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PETS PETMED EXPRESS INC Stock $pets

2020 Q1 Form 10-K Financial Statement

#000143774920011720 Filed on May 26, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PETS
PETMED EXPRESS INC Stock $pets